Publication | Closed Access

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data

Hematological MalignancyCell TherapyCompassionate Use DataMedicineImmunologyCd34+ CellsImmunoeditingAutoimmunityMultiple Myeloma PatientsImmunotherapyOncologyRadiation Oncology